Home > Insider Trading > Filing (0001209191-20-020124)

Filing Details

Accession Number:: 0001209191-20-020124
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-18 20:14:00
Reporting Period:: 2020-03-16

Accepted Time:: 2020-03-18 20:14:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1711279	Krystal Biotech Inc.	KRYS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1298711	Suma Krishnan	C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203	Chief Operating Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-03-16	2,559	$40.14	1,948,903	No	4	S	Direct
Common Stock	Disposition	2020-03-17	10,780	$40.49	1,938,123	No	4	S	Direct
Common Stock	Disposition	2020-03-17	1,396	$41.27	1,936,727	No	4	S	Direct
Common Stock	Disposition	2020-03-17	4	$42.03	1,936,723	No	4	S	Direct
Common Stock	Disposition	2020-03-18	659	$40.20	1,936,064	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	112,162	Indirect	By trust
Common Stock	1,936,462	Indirect	By spouse

Footnotes

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.
This transaction was executed in multiple trades ranging from $40.00 to $40.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
This transaction was executed in multiple trades ranging from $40.00 to $40.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
This transaction was executed in multiple trades ranging from $41.00 to $41.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
This transaction was executed in multiple trades ranging from $40.00 to $40.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
Directly beneficially owned by Krish S. Krishnan, the spouse of the reporting person.